Akso Health Group current report, Q2 FY2024

Akso Health Group Form 6-K Summary

Business Context and Reporting Period

This Form 6-K, filed on May 2, 2024, reports the results of the 2024 Annual General Meeting (AGM) held by Akso Health Group on April 30, 2024. The meeting took place in Qingdao, China, with a quorum of 387,411,853 ordinary shares representing approximately 88% of the 440,051,460 shares issued and outstanding.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance actions and shareholder voting results rather than financial performance data.

Material Changes and Corporate Actions

Shareholders approved several material resolutions at the AGM:

  • Director Elections: Five directors were elected to hold office until the next annual meeting.
  • Auditor Ratification: OneStop Assurance PAC was appointed as the independent registered public accounting firm for the fiscal year ending March 31, 2025.
  • Share Capital Restructuring: The company reclassified its authorized share capital into two classes:
    • Class A Ordinary Shares: 4,500,000,000 authorized shares (including 320,770,660 issued and outstanding held by shareholders other than Webao Limited).
    • Class B Ordinary Shares: 500,000,000 authorized shares (including 7,980,800 issued and outstanding held by Webao Limited).
  • Amended M&A: The Second Amended and Restated Memorandum and Articles of Association were approved to reflect the new share structure.

Voting Results

Resolution For Against Abstain Total Votes
Appointment of Directors 387,384,775 26,883 195 387,411,853
Ratification of Auditor 387,388,912 22,896 45 387,411,853
Amendment to Authorized Share Capital 386,748,223 662,595 1,035 387,411,853
Approval of Amended M&A 386,751,052 660,006 795 387,411,853

Outlook and Risks

The filing does not contain management commentary on future guidance, risks, contingencies, or unusual items. The document is strictly a record of the AGM proceedings.

Key Facts for Investor Verification

  • Verify the specific voting rights and economic privileges attached to the newly created Class A and Class B ordinary shares in the Amended M&A.
  • Confirm the identity and background of the five newly elected directors.
  • Review the engagement letter or scope of work for the newly appointed auditor, OneStop Assurance PAC.
  • Check subsequent filings for the official effective date of the share capital reclassification.